UBS Group’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75.4K | Sell |
|
|||||
|
2025
Q1 | $99.1K | Buy |
|
|||||
|
2024
Q4 | $89.5K | Buy |
|
|||||
|
2024
Q3 | $6.33K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $6.94K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $207 | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $65 | Sell |
|
|||||
|
2022
Q3 | $7K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $8K | Buy |
|
|||||
|
2021
Q4 | $3K | Sell |
|
|||||
|
2021
Q3 | $16K | Buy |
|